In the first pharmaphorum podcast of 2020 Roche’s Conor Megaw talks about his company’s approach to big data and how some of its partnerships have been performing.
NICE has said in first draft guidance that Roche’s Tecentriq should not get regular NHS funding as a treatment for a kind of advanced lung cancer, citing “highly uncertain” data about the d
